Inotek announces phase II topline results for trabodenoson/latanoprost in glaucoma July 10, 2017 No Comments
ProQR Therapeutics receives orphan drug designations in E.U. and U.S. for QRX-411 July 7, 2017 No Comments
Antisense oligonucleotide QRX-411 named FDA orphan drug for retinitis pigmentosa July 4, 2017 No Comments
pSivida submits MAA in E.U. for Durasert 3-year treatment for posterior segment uveitis June 27, 2017 No Comments
Phase II results show beneficial effects of NT-501 in patients with macular telangiectasia type 2 June 21, 2017 No Comments
RSS